Hypertrophy of the noninfarcted left ventricle as a chronic response to myocardial infarction has been demonstrated in animals and at autopsy in humans. However, the functional significance of postmyocardial infarction hypertrophy is a subject of dispute. The purpose of this study was to determine the time course of development of postmyocardial infarction hypertrophy of the noninfarcted myocardium in humans and to assess its functional significance. Subcostal view, two-dimensional echocardiograms were recorded at rest and during peak exercise, 6 and 40 weeks postmyocardial infarction in 45 patients (16 anterior, 20 
Hypertrophy of the noninfarcted left ventricle as a chronic response to myocardial infarction has been demonstrated in animals and at autopsy in humans. However, the functional significance of postmyocardial infarction hypertrophy is a subject of dispute. The purpose of this study was to determine the time course of development of postmyocardial infarction hypertrophy of the noninfarcted myocardium in humans and to assess its functional significance. Subcostal view, two-dimensional echocardiograms were recorded at rest and during peak exercise, 6 and 40 weeks postmyocardial infarction in 45 patients (16 anterior, 20 inferior, nine non-Q wave infarcts), for measurement of left ventricular mass and ejection fraction. The left ventricular mass index increased from 94±30 to 118±27 g/m2 (p<0.01) during the time of the two studies. There was a significant correlation between the change in left ventricular mass index and improved resting ejection fraction (r=0.48, p<0.001) and exercise ejection fraction (r=0.48, p <0.001) at the follow-up study. Of the 32 patients who increased their left ventricular mass index >7%, 18 improved their rest ejection fraction >0.05 units and 17 improved their exercise ejection fraction >0.05 units. Conversely, of the 13 patients who failed to increase their left ventricular mass index, only three improved their rest ejection fraction and one improved the exercise ejection fraction (Fisher's exact test, p<0.05). We reached three conclusions. First, in humans, significant hypertrophy of the noninfarcted myocardium can be detected by two-dimensional echocardiography, 9 months postmyocardial infarction. Second, patients who demonstrate hypertrophy of the noninfarcted myocardium are more likely to demonstrate improved rest and exercise ejection fraction than those who do not. Third, postmyocardial infarction left ventricular hypertrophy may, therefore, represent a beneficial chronic adaptation to the loss of myocardium after myocardial infarction. (Circulation 1989; 80:816-822) H ypertrophy of the noninfarcted myocar- dium has been demonstrated to occur as a chronic response to myocardial infarction in several animal species.1-4However, the functional significance of the hypertrophy has been unclear because of a paucity of studies relating changes in hemodynamic and left ventricular functional parameters to the development of the hypertrophy longterm postinfarction. For example, Anversa et a14 demonstrated that the hypertrophy alters myocardial capillary density and epicardial to endocardial blood flow ratios, and they proposed that it might result in subendocardial ischemia and worsened left ventric-other hand, if the hypertrophy were not accompanied by chronic ischemia, it would increase the amount of normal viable myocardium and, thereby, might result in improved left ventricular function ("physiologic hypertrophy").2,6,7 Indeed, hyperfunction of the normal myocardium associated with changes consistent with hypertrophy have been reported in dogs 4 weeks postinfarction. 8 We have previously reported that hypertrophy of the noninfarcted myocardium occurs in dogs as a chronic response to the infarction. 9 The time course of the development of the hypertrophy as detected by serial two-dimensional echocardiograms approximately paralleled the improvement in resting left ventricular ejection fraction, and the magnitude of hypertrophy correlated significantly with the degree of recovery of resting left ventricular ejection fraction, suggesting that the hypertrophy observed in dogs has a salutary effect on resting left ventricular function. Although left ventricular hypertrophy has been well documented at autopsy in patients with coronary artery disease,10-12 and thickening of the noninfarcted left ventricular wall assessed by echocardiography has been reported in humans,13,14 there are no studies that have reported serial changes in left ventricular mass in patients recovering from myocardial infarction. Thus, it is not known whether humans adapt to loss of myocardium by developing hypertrophy of the remaining myocardium to the same degree and time course as do other species. It is also unknown whether such hypertrophy is related to improvement in either resting or exercise left ventricular function (physiologic hypertrophy) or has adverse effects on left ventricular function (pathologic hypertrophy). The purpose of this study, therefore, was 1) to determine the time course of hypertrophy of the noninfarcted myocardium following acute myocardial infarction in humans and 2) to assess the functional significance of the postinfarction hypertrophy by relating its development to changes in ejection fraction at rest and at peak exercise. The end-diastolic (onset of the electrocardiographic QRS) wave and end-systolic (smallest left ventricular cavity just prior to mitral valve opening) frames were identified by slow motion and frameby-frame review of the videotape, in which all or nearly all of the endocardial and epicardial contours could be visualized on a single stop-frame image.
Methods
Patients, in whom images of adequate quality could not be obtained at rest, were excluded from the study. Patients, in whom an adequate resting study could be obtained at the initial study, uniformly had adequate images obtainable at peak exercise and at the follow-up study. The endocardium was identified as the interface between the myocardial echoes and the cavity echoes, and the epicardial echoes were defined as the middle of the brightest pericardial echoes. The endocardial and epicardial borders were identified visually and traced manually for transfer to a microcomputer, using an XY digitizer directly overlaid on the video image (Dextra D-100 
Sequential Studies
The patients were studied on two occasions. The first was 4-6 weeks (mean, 5.5 weeks) following their myocardial infarction. The protocol was repeated 6-9 months postinfarction (mean, 8 In a previous study of the variability of left ventricular mass measurements in dogs, using the equipment and procedures described in the present study,19 we reported that an increase in calculated left ventricular mass of 7% must occur for the 95% confidence limits of the measurement (defined as 1.96xSD/the square root of the sample size) to be exceeded. Thus, in this study, we defined a change in calculated left ventricular mass of at least 7% as significant hypertrophy. By this definition, 32 of the 45 patients in the present study had a significant increase in left ventricular mass between the initial and follow-up studies. There was no significant difference between the patients who did or did not develop hypertrophy with regard to medications taken (nitrates, /8-blockers, or calcium channel blockers).
Changes in Rest and Exercise Ejection Fraction
At the time of the initial study, the patients with a non-Q wave infarction had a higher resting ejection fraction (0.53±0.16) than did the patients with anterior myocardial infarction (0.38±0. 13,p=0.002) or the patients with inferior infarcts (0.42±0.14, p=0.002). However, there were no significant changes between the initial and follow-up studies in either rest (Figure 2 ) or exercise (Figure 3 ) ejection fraction for the anterior, inferior, or non-Q wave infarct patients.
Relation of Increased Left Ventricular Mass Index to Changes in Rest and Exercise Left Venticular Function
There were significant differences in improvement in rest and exercise ejection fraction between the patients who increased their left ventricular mass and those who did not. Of the 32 patients who significantly increased their left ventricular mass as previously defined, 18 increased their resting ejection fraction by at least 0.04 units (the 95% confidence limits, as defined for a normal population, as previously reported by this laboratory)22 (Figure 4) , and 17 increased their peak exercise ejection fraction ( Figure 5 ) from the initial study to the follow-up study. In contrast, of the 13 patients who failed to increase their left ventricular mass, only three improved their rest ejection fraction and one improved the peak exercise ejection fraction (Fisher's exact test,p=0.05, for resting ejection fraction changes, and p =0.01, for exercise ejection fraction changes) (Figures 4 and 5) . For the entire patient population, the increase in left ventricular mass index correlated significantly with increases in both resting (r=0.48, p<0.001) (Figure 4 ) and the peak exercise (r=0.48,p<0.001) ( Figure 5 ) ejection fraction between the two studies.
Patients with a single infarct had a significant correlation between left ventricular mass increase and improved rest (r=0.54,p=0.001) and exercise (r=0.51, p<O.OOl) ejection fraction. In the eight patients with multiple infarcts, the relation between development of hypertrophy and improved ejection fraction did not attain significance. For the entire group, there was no significant relation between increased left ventricular mass and changes in ejection fraction from rest to peak exercise between the two studies.
Discussion
Hypertrophy of the noninfarcted myocardium has been demonstrated to occur as a chronic response to acute myocardial infarction in several animal studies.1-4 Some authors have hypothesized that this response represents a beneficial "compensatory" adaptation to the loss of myocardium from the acute myocardial infarction.2,6'7 However, others have questioned whether the hypertrophy is a beneficial response and have observed that the hypertrophied myocardium in rats has reduced cap- (Figures 4 and 5) . The hypertrophy appears to be most beneficial in patients sustaining a first myocardial infarction, raising the possibility that patients who have sustained multiple infarcts may have too little remaining viable myocardium to compensate with a functional hypertrophic response.
In this study, the correlation between the observed left ventricular hypertrophy and improved rest and exercise ejection fraction was only moderate, although highly significant. There are several potential reasons for the observed correlation. First, the patient population was heterogeneous, with variable age, gender, infarct location, multiplicity of infarcts, and previous hypertension. In addition, patient activity levels were not controlled during the study, and it is possible that some patients may have engaged in significantly higher levels of exercise training than others. However, the fact that the correlation between the hypertrophy and improved left ventricular function was significant indicates that at least part of the improved ejection fraction was related to hypertrophy of the noninfarcted myocardium, even though the pathogenesis of the improved ejection fraction clearly is multifactorial.
There are abundant clinical and animal data to suggest that improvements in ejection fraction following myocardial infarction are multifactorial,27-33 with both acute and chronic adaptations. Ejection fraction in patients often spontaneously improves during the first 2 weeks postinfarction, independent of specific therapy.28,31 Early in acute infarction, plasma catecholamine levels increase markedly,34-36 but this is followed by down-regulation of ,Breceptors resulting in a blunted response to inotropic stimulation during recovery. 37 In animal studies, acute protein synthesis is preferentially shifted toward increased mitochondria and other elements necessary for contractile function,29 and, days to weeks later, shifts to enhanced production of myofilaments.30 Thus, recovery from an acute myocardial infarction is facilitated by multiple mechanisms that are different in the acute and chronic phase. Hypertrophy of the noninfarcted myocardium appears to be an important chronic factor leading to improved rest and exercise left ventricu-lar function, but which probably has little or no role as an early adaptation to the myocardial infarction.
Critique of Methodology
In this study the accuracy and reproducibility of the measurements of left ventricular mass and ejection fraction are important to the conclusions reached. We have reported, in a previous study,19 on the accuracy and reproducibility of twodimensional echocardiographic estimates of left ventricular mass compared to autopsy left ventricular weight in dogs with and without myocardial infarction. The reproducibility of echocardiographic left ventricular mass estimates using the equipment and methods described here was significant (r=0.88, p=0.001, in 12 normal dogs; and r=0.84, p=0.005, in 10 dogs three months postinfarction). However, the SEE was approximately 12%, making a 7% change in estimated left ventricular mass a requirement for exceeding the 95% confidence limits of the test. For this reason, an increase of at least 7% in left ventricular mass was used in this study as the point at which we concluded that detectable hypertrophy had occurred in an individual patient (32 of the 45 patients had hypertrophy by this criterion). Other laboratories have recently reported accuracy and reproducibility measurements similar to this study. 18, 21 This laboratory has also compared the twodimensional echocardiographic measurements of left ventricular ejection fraction at rest and exercise in coronary artery disease patients with first-pass radionuclide angiography (r=0.91, p=0.001). 22 The 95% confidence limit reproducibility of two-dimensional echocardiographic measurements of ejection fraction in this laboratory is 0.04 units. This also is similar to the reproducibility reported by other laboratories.18,21 Thus, in this study, changes in both left ventricular mass and ejection fraction were observed that were significantly greater than may be expected solely on the basis of methodologic variability.
Medications taken, the presence of hypertension, and differences in exercise capacity, potentially, could affect the magnitude of hypertrophy observed in this study. However, there were no significant differences between the initial and follow-up studies in any of these parameters, and there was no correlation between these parameters and the magnitude of hypertrophy observed. Significant obstruction of coronary arteries in other portions of the left ventricle may conceivably result in chronic ischemia and may significantly affect the development of left ventricular hypertrophy. Unfortunately, cardiac catheterization was not a routine part of the study protocol; hence, the potential significance of chronic ischemia cannot be addressed by this study.
Conclusions
Our study has demonstrated that hypertrophy of the noninfarcted myocardium occurs in humans and can be detected by two-dimensional echocardiography within 9 months after incurring a myocardial infarction. Patients who develop hypertrophy of the noninfarcted myocardium are more likely to develop improved rest and exercise left ventricular function than those who do not. Postinfarction hypertrophy of the noninfarcted myocardium, therefore, appears to represent a beneficial chronic adaptation to the loss of myocardium following an acute myocardial infarction.
